Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis

References

• BulacioLPazMRamadanSRamosLOral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy, identification of the yeasts and evaluation of their antifungal susceptibilityJ Med Mycol201222348353
   PubMed Web of Science ®Google Scholar
• MangTSMikulskiLHallREPhotodynamic inactivation of normal and antifungal resistant Candida speciesPhotodiagn Photodyn Ther2010798105
   PubMed Web of Science ®Google Scholar
• Mc CarronPADonnelyRFCanningPEBioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidiasisBiomaterials2004252399240714741605
   PubMed Web of Science ®Google Scholar
• CossuAWangMSChaudhariANitinNAntifungal activity against Candida albicans of starch Pickering emulsion with thymol or amphotericin B in suspension and calcium alginate filmsInt J Pharm201549323324226231107
   PubMedGoogle Scholar
• SamaranayakeYHSamaranayakeLPExperimental oral candidiasis in animal modelsClin Microbiol Rev20011439842911292645
   PubMed Web of Science ®Google Scholar
• YehiaSAEl-GazayerlyONBasaliusEBDesign and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug releaseAAPS PharmSciTech200891207121719082739
   PubMed Web of Science ®Google Scholar
• Mohamed SaifullaPMuzzammılSPramod KumarTMPreparation of fluconazole buccal tablet and influence of formulation expedients on its propertiesActa Pharm Sin2011464460465
   Google Scholar
• MoosaMYSobelJDElhalisHFungicidal activity of fluconazole against Candida albicans in a synthetic vagina-simulative mediumAntimicrob Agents Chemother201448116116714693534
   PubMedGoogle Scholar
• KoksCMeenhorstPHillebrandMPharmacokinetics of fluconazole in saliva and plasma after administration of an oral suspension and capsulesAntimicrob Agents Chemother199640193519378843308
   PubMed Web of Science ®Google Scholar
• SoadAYOmaimaNEEmadBBDesign and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug releaseAAPS PharmSciTech2008941207121719082739
   PubMed Web of Science ®Google Scholar
• KashappaGHPramodTMPreparation and evaluation of a novel buccal adhesive systemAAPS PharmSciTech200453e3515760069
   PubMed Web of Science ®Google Scholar
• LiuMZhangJZhuXEfficient mucus permeation and tight junction opening by dissociable mucus-inert agent coated trimethyl chitosan nanoparticles for oral insulin deliveryJ Control Release2016222677726686663
   PubMed Web of Science ®Google Scholar
• MazzarinoLBorsaliRLemos-SennaEMucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin releasePharm Nanotechnol201410337643771
   Google Scholar
• AlmalikADonnoRCadmanCJHyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentationJ Control Release20131721142115024103813
   PubMed Web of Science ®Google Scholar
• BhavsarMDShenoyDBAmijiMMPolymeric nanoparticles for delivery in the gastro-intestinal tractTorchilinVPNanoparticulates as Drug CarriersLondon, UKWorld Scientific Publishing Co. Pte. Ltd2006629633
   Google Scholar
• CuiFQianFYinFPreparation and characterization of mucoadhesive polymer-coated nanoparticlesInt J Pharm200631615416116567070
   PubMed Web of Science ®Google Scholar
• GundogduEIlem-OzdemirDEkinciMOzgencEAsikogluMRadiolabeling efficiency and cell incorporation of chitosan nanoparticlesJ Drug Deliv Sci Technol2015298489
   Web of Science ®Google Scholar
• NeedlemanIGSmalesFCMartinGPAn investigation of bioadhesion for periodontal and oral mucosal drug deliveryJ Clin Periodontol1997243944009205918
   PubMed Web of Science ®Google Scholar
• HembramKCPrabhaSChandraRAdvances in preparation and characterization of chitosan nanoparticles for therapeuticsArtif Cells Nanomedicine Biotechnol2016441305314
   Web of Science ®Google Scholar
• JungJYYooSDLeeSHEnhanced solubility and dissolution rate of itraconazole by a solid dispersion techniqueInt J Pharm199918720921810502627
   PubMed Web of Science ®Google Scholar
• Abdel-WahhabMAAbdel-WahhabKGMannaaFAUptake of Eudragit Retard L (Eudragit® RL) nanoparticles by human THP-1 cell line and its effects on hematology and erythrocyte damage in ratsMaterials2014715551572
   Web of Science ®Google Scholar
• PignatelloRBucoloCPuglisiGOcular tolerability of eudragit RS 100® and RL100® nanosuspensions as carriers for ophthalmic controlled drug deliveryJ Pharm Sci200291122636264112434408
   PubMed Web of Science ®Google Scholar
• SemaltyMSemaltyAKumarGFormulation and characterization of mucoadhesive buccal films of glipizideInd J Pharm Sci2008704348
   PubMed Web of Science ®Google Scholar
• DiarraMPourroyGBoymondCMusterDFluoride controlled release tablets for intra buccal useBiomaterials2003241293130012527271
   PubMed Web of Science ®Google Scholar
• BodmeierRChenHTylePJaroszPSpontaneous formation of drug-containing acrylic nanoparticlesJ Microencapsulation1991821611701765898
   PubMed Web of Science ®Google Scholar
• CamposAMDieboldYCarvalhoELSChitosan nanoparticles as new ocular drug delivery dystems: in vitro stability, in vivo fate and cellular toxicityPharm Res20042180380715180338
   PubMed Web of Science ®Google Scholar
• BhattaRSChandasanaHChhonkerYSMucoadhesive nanoparticles for prolonged ocular delivery of natamycin: In vitro and pharmacokinetics studiesInt J Pharm201243210511222569234
   PubMed Web of Science ®Google Scholar
• ŞenyiğitTSonvicoFBarbieriSLecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skinJ Control Release201014236837319932722
   PubMed Web of Science ®Google Scholar
• Üstündağ-OkurNGökçeEHBozbıyıkDIPreparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitisEur J Pharm Sci20146320421525111119
   PubMed Web of Science ®Google Scholar
• RitgerPLPeppasNAA simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJ Control Release198753742
   Google Scholar
• KeckCMMullerRHNanotoxicological classification system (NCS) – a guide for the risk-benefit assessment of nanoparticulate drug delivery systemsEur J Pharm Biopharm20138444544823333302
   PubMed Web of Science ®Google Scholar
• IbrahimHKEl-LeithyISMakkyAAMucoadhesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone bitherapyMol Pharm20107257658520163167
   PubMedGoogle Scholar
• YonchevaKVandervoortJLudwigADevelopment of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular applicationPharm Dev Technol2011161293520038266
   PubMed Web of Science ®Google Scholar
• ChopraAKMarwahaRKKaushikDDurejaHBox-Behnken designed fluconazole loaded chitosan nanoparticles for ocular deliveryJ Pharm Drug Deliv Res201431
   Google Scholar
• XiangJFangXLiXTransbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigationInt J Pharm2002231576611719014
   PubMed Web of Science ®Google Scholar
• ZangRLiDTangICWangJYangSTCell-based assays in high-throughput screening for drug discoveryInt J Biotechnol Wellness Industries201213151
   Google Scholar
• WeyermannJLochmannDZimmerAA practical note on the use of cytotoxicity assaysInt J Pharm200528836937615620877
   PubMed Web of Science ®Google Scholar